Trouble for Bliss GVS Pharma Drug in Ghana

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Trouble is brewing in the Ghana market for Bliss GVS Pharma, over an anti-malarial product sold by it in the African country. Ghana’s Food and Drugs Authority has said that it black-listed Bliss from “manufacturing of medicines and other medicinal products for the Ghanaian market.” The company had made a fake anti-malarial medicine (Gsunate plus suppositories), which was imported into the Ghana market.

Help employers find you! Check out all the jobs and post your resume.

Back to news